3.31USD
63.79 MUSD
921.01 MUSD
11.28 M
About USANA Health Sciences, Inc.
Sector
CEO
Jim H. Brown
Headquarters
Salt Lake City
Website
Employees (FY)
1.8 K
Founded
1992
ISIN
US90328M1071
FIGI
BBG000BX28M0
USANA Health Sciences, Inc. develops and manufactures nutritional, personal care and weight-management products. It operates under the following segments: USANA Nutritionals, USANA Foods, Personal Care and Skincare, and All Other. The firm's brands include Procosa and MagneCal D. The company was founded by Myron W. Wentz in September 1992 and is headquartered in Salt Lake City, UT.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Curated watchlists where USNA is featured.
Frequently Asked Questions
The current price of USNA is 43.40 USD — it has increased by 0.91% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on NYSE exchange USANA Health Sciences, Inc. stocks are traded under the ticker USNA.
USANA Health Sciences, Inc. is going to release the next earnings report on Apr 30, 2024. Keep track of upcoming events with our Earnings Calendar.
USNA stock is 1.51% volatile and has beta coefficient of 0.97. Check out the list of the most volatile stocks — is USANA Health Sciences, Inc. there?
One year price forecast for USANA Health Sciences, Inc. has a max estimate of 65.00 USD and a min estimate of 48.00 USD.
USNA earnings for the last quarter are 0.59 USD whereas the estimation was 0.59 USD which accounts for −0.48% surprise. Estimated earnings for the next quarter are 0.52 USD. See more details about USANA Health Sciences, Inc. earnings.
USANA Health Sciences, Inc. revenue for the last quarter amounts to 213.37 M USD despite the estimated figure of 212.80 M USD. In the next quarter revenue is expected to reach 212.42 M USD.
Yes, you can track USANA Health Sciences, Inc. financials in yearly and quarterly reports right on TradingView.
USNA stock has fallen by 5.53% compared to the previous week, the month change is a 11.43% fall, over the last year USANA Health Sciences, Inc. has showed a 31.97% decrease.
USNA net income for the last quarter is 16.77 M USD, while the quarter before that showed 11.35 M USD of net income which accounts for 47.76% change. Track more USANA Health Sciences, Inc. financial stats to get the full picture.
Today USANA Health Sciences, Inc. has the market capitalization of 827.53 M, it has increased by 0.17% over the last week.
No, USNA doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, USNA shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade USANA Health Sciences, Inc. stock right from TradingView charts — choose your broker and connect to your account.
As of Apr 18, 2024, the company has 1.80 K employees. See our rating of the largest employees — is USANA Health Sciences, Inc. on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So USANA Health Sciences, Inc. technincal analysis shows the sell today, and its 1 week rating is strong sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating USANA Health Sciences, Inc. stock shows the strong sell signal. See more of USANA Health Sciences, Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.
We've gathered analysts' opinions on USANA Health Sciences, Inc. future price: according to them, USNA price has a max estimate of 65.00 USD and a min estimate of 48.00 USD. Read a more detailed USANA Health Sciences, Inc. forecast: see what analysts think of USANA Health Sciences, Inc. and suggest that you do with its stocks.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. USANA Health Sciences, Inc. EBITDA is 113.47 M USD, and current EBITDA margin is 12.32%. See more stats in USANA Health Sciences, Inc. financial statements.